EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, West Pharmaceutical Services's enterprise value is $27,024 Mil.
West Pharmaceutical Services's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,950 Mil. Therefore, West Pharmaceutical Services's EV-to-Revenue for today is 9.16.
The historical rank and industry rank for West Pharmaceutical Services's EV-to-Revenue or its related term are showing as below:
WST'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.91 Med: 4.79 Max: 13.83
Current: 9.16
During the past 13 years, the highest EV-to-Revenue of West Pharmaceutical Services was 13.83. The lowest was 1.91. And the median was 4.79.
WST's EV-to-Revenue is ranked worse than 80.99% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: 2.925
vs WST: 9.16
As of today (2024-04-19), West Pharmaceutical Services's stock price is $374.01.
West Pharmaceutical Services's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $39.19. Therefore, West Pharmaceutical Services's PS Ratio for today is 9.54.
West Pharmaceutical Services EV-to-Revenue Historical Data
The historical data trend for West Pharmaceutical Services's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
West Pharmaceutical Services Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
5.99
9.63
12.14
5.84
8.59
West Pharmaceutical Services Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
5.84
8.72
9.69
9.29
8.59
Competitive Comparison
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services EV-to-Revenue Distribution
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's EV-to-Revenue falls into.
West Pharmaceutical Services EV-to-Revenue Calculation
West Pharmaceutical Services's current Enterprise Value is $27,024 Mil.
West Pharmaceutical Services's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,950 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services (NYSE:WST) EV-to-Revenue Explanation
West Pharmaceutical Services's share price for today is $374.01.
West Pharmaceutical Services's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $39.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of West Pharmaceutical Services's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
West Pharmaceutical Services (West Pharmaceutical Services) Business Description
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WST has been successfully added to your 